Analyst Recommendations

Wells Fargo analyst issues BUY recommendation for RCL on February 26, 2024 08:01AM ET. The previous analyst recommendation was Buy.RCL was trading at $121.91 at issue of the...

February 26, 2024   RCL -0.46%

Wells Fargo analyst issues OVERWEIGHT recommendation for OHI on February 26, 2024 05:24AM ET. OHI was trading at $31.12 at issue of the analyst recommendation.The overall analyst consensus...

February 26, 2024   OHI -0.52%

Wells Fargo analyst issues OVERWEIGHT recommendation for NHI on February 26, 2024 05:24AM ET. The previous analyst recommendation was Equal-Weight.NHI was trading at $57.76 at issue of the...

February 26, 2024   NHI -0.83%

Piper Sandler analyst issues OVERWEIGHT recommendation for CE on February 26, 2024 03:50AM ET. The previous analyst recommendation was Neutral.CE was trading at $149.38 at issue of the...

February 26, 2024   CE -2.83%

Keefe, Bruyette & Woods analyst issues OUTPERFORM recommendation for FMCC on February 26, 2024 03:07AM ET. The previous analyst recommendation was Market Perform.FMCC was trading at $1.0701 at...

February 26, 2024   FMCC -4.82%

Keefe, Bruyette & Woods analyst issues OUTPERFORM recommendation for ROOT on February 26, 2024 03:07AM ET. The previous analyst recommendation was Market Perform.ROOT was trading at $16.96 at...

February 26, 2024   ROOT 4.10%

HSBC analyst issues BUY recommendation for TT on February 24, 2024 11:48PM ET. The previous analyst recommendation was Hold.TT was trading at $0 at issue of the analyst...

February 26, 2024   TT -0.73%

Wedbush analyst issues OUTPERFORM recommendation for NICE on February 23, 2024 02:39PM ET. The previous analyst recommendation was Outperform.NICE was trading at $238.6 at issue of the analyst...

February 23, 2024   NICE -1.86%

RBC Capital analyst issues OUTPERFORM recommendation for NICE on February 23, 2024 02:39PM ET. The previous analyst recommendation was Outperform.NICE was trading at $238.6 at issue of the...

February 23, 2024   NICE -1.86%

William Blair analyst issues OUTPERFORM recommendation for MRVI on February 23, 2024 02:07PM ET. The previous analyst recommendation was Outperform.MRVI was trading at $8.25 at issue of the...

February 23, 2024   MRVI -2.70%